4
Changes in Ownership
Encompass Health Corp Filed Acc 0001127602-25-015049
President & CEO sold 118,384 shares at an average $121.53 ($14,387,152)
- President & CEO acquired 118,384 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Tarr Mark J President & CEO | 2025-05-20 | Option exercise | +56,306 | $35.06 | $1,974,088 | 583,376 | D: show line 1 in the form |
| Tarr Mark J President & CEO | 2025-05-20 | Option exercise | +62,078 | $44.67 | $2,773,024 | 645,454 | D: show line 2 in the form |
| Tarr Mark J President & CEO | 2025-05-20 | Sale | −94 | $120.94 | $11,368 | 645,360 | D: show line 3 in the form |
| Tarr Mark J President & CEO | 2025-05-20 | Sale | −118,290 | $121.53 | $14,375,784 | 527,070 | D: show line 4 in the form |
| Open-market sales · 118,384 sh · avg $121.53 · $14,387,152 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Tarr Mark J President & CEO | 2025-05-20 | Option exercise · Non-qualified Stock Option (Right to Buy) | −56,306 | 0 | D: show line 5 in the form | |||||
| Tarr Mark J President & CEO | 2025-05-20 | Option exercise · Non-qualified Stock Option (Right to Buy) | −62,078 | 0 | D: show line 6 in the form |
Loading xslF345X05/form4.xml…